Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06CJP
|
||||
Former ID |
DNC007350
|
||||
Drug Name |
4-chloro-1-guanidino-7-isoquinolinesulphonamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528796] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H10ClN5O2S
|
||||
Canonical SMILES |
C1=CC2=C(C=C1S(=O)(=O)N)C(=NC=C2Cl)N=C(N)N
|
||||
InChI |
1S/C10H10ClN5O2S/c11-8-4-15-9(16-10(12)13)7-3-5(19(14,17)18)1-2-6(7)8/h1-4H,(H2,14,17,18)(H4,12,13,15,16)
|
||||
InChIKey |
FXVHAOFNNRNCRJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Urokinase-type plasminogen activator | Target Info | Inhibitor | [528796] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | Beta1 integrin cell surface interactions | ||||
E2F transcription factor network | |||||
Beta3 integrin cell surface interactions | |||||
Osteopontin-mediated events | |||||
Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
amb2 Integrin signaling | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
Beta2 integrin cell surface interactions | |||||
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||||
Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
FGF signaling pathway | |||||
Reactome | Dissolution of Fibrin Clot | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.